(Total Views: 478)
Posted On: 10/17/2025 9:38:28 AM
Post# of 158046
Merck's #'s ---
Yearly sales: $65B
Yearly profit: $16B
Shares outstanding: 2.5b
$65B ÷ by 12 = $5.5B monthly sales
$16B + by 12 = $1.X.3B monthly profit
Takes almost 1 of profit just to on par the share structure.
& are $50B yearly operating costs..
__
What Cytodyn is building via LL:
No need for:
A bloated corporate structure of 40,50,60k employees.
100's of lawyers.
Massive Regulatory dept.
A world- wide sales team(s), etc..
Have blabbed a couple times that Leronlimab will make Cytodyn the leanest, most profitable pharma, in history.
Dr. J's Aug video, Mr. Hoffmans LL/ICI comment for patients worldwide, & now the Dr. J RX interview, only reinforced to me the above Cytodyn leverage.
Yearly sales: $65B
Yearly profit: $16B
Shares outstanding: 2.5b
$65B ÷ by 12 = $5.5B monthly sales
$16B + by 12 = $1.X.3B monthly profit
Takes almost 1 of profit just to on par the share structure.
& are $50B yearly operating costs..
__
What Cytodyn is building via LL:
No need for:
A bloated corporate structure of 40,50,60k employees.
100's of lawyers.
Massive Regulatory dept.
A world- wide sales team(s), etc..
Have blabbed a couple times that Leronlimab will make Cytodyn the leanest, most profitable pharma, in history.
Dr. J's Aug video, Mr. Hoffmans LL/ICI comment for patients worldwide, & now the Dr. J RX interview, only reinforced to me the above Cytodyn leverage.
(4)
(0)
